Asset Details
Do you wish to reserve the book?
Biopolymer-coated gold nanoparticles inhibit human insulin amyloid fibrillation
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Biopolymer-coated gold nanoparticles inhibit human insulin amyloid fibrillation
Do you wish to request the book?
Biopolymer-coated gold nanoparticles inhibit human insulin amyloid fibrillation
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Biopolymer-coated gold nanoparticles inhibit human insulin amyloid fibrillation
2020
Overview
Deposits of protein misfolding and/or aggregates are a pathological hallmark of amyloid-related diseases. For instance, insulin amyloid fibril deposits have been observed in patients with insulin-dependent diabetes mellitus after insulin administration. Here, we report on the use of AuNPs functionalized with linear- (i.e. dextrin and chitosan) and branched- (i.e. dextran-40 and dextran-10) biopolymers as potential agents to inhibit insulin fibril formation. Our dynamic light scattering analyses showed a size decrease of the amyloid fibrils in the presence of functionalized AuNPs. Circular dichroism spectroscopy as well as enzyme-linked immunosorbent assay data demonstrated that the secondary structural transition from α-helix to β-sheet (which is characteristic for insulin amyloid fibril formation) was significantly suppressed by all biopolymer-coated AuNPs, and in particular, by those functionalized with linear biopolymers. Both transmission electron microscopy and atomic force microscopy analyses showed that the long thick amyloid fibrils formed by insulin alone become shorter, thinner or cluster when incubated with biopolymer-coated AuNPs. Dextrin- and chitosan-coated AuNPs were found to be the best inhibitors of the fibril formation. Based on these results, we propose a mechanism for the inhibition of insulin amyloid fibrils: biopolymer-coated AuNPsstrongly interact with the insulin monomers and inhibit the oligomer formation as well as elongation of the protofibrils.Moreover, cytotoxicity experiments showed that AuNP-insulin amyloid fibrils are less toxic compared to insulin amyloid fibrils alone. Our results suggest that both dextrin- and chitosan-AuNPs could be used as therapeutic agents for the treatment of amyloid-related disorders.
Publisher
Nature Publishing Group UK,Nature Publishing Group
Subject
/ Amyloidosis - prevention & control
/ Chitosan
/ Circular Dichroism - methods
/ Coated Materials, Biocompatible - chemistry
/ Coated Materials, Biocompatible - pharmacology
/ Coatings
/ Dextran
/ Dextrin
/ Diabetes mellitus (insulin dependent)
/ Enzyme-linked immunosorbent assay
/ Fibrils
/ Humanities and Social Sciences
/ Humans
/ Insulin
/ Metal Nanoparticles - administration & dosage
/ Metal Nanoparticles - chemistry
/ Metal Nanoparticles - ultrastructure
/ Microscopy, Atomic Force - methods
/ Microscopy, Electron, Transmission - methods
/ Monomers
/ Science
